A detailed history of Victory Capital Management Inc transactions in Bluebird Bio, Inc. stock. As of the latest transaction made, Victory Capital Management Inc holds 24,311 shares of BLUE stock, worth $223,174. This represents 0.0% of its overall portfolio holdings.

Number of Shares
24,311
Previous 24,494 0.75%
Holding current value
$223,174
Previous $24,000 50.0%
% of portfolio
0.0%
Previous 0.0%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

SELL
$0.47 - $1.35 $86 - $247
-183 Reduced 0.75%
24,311 $12,000
Q2 2024

Aug 05, 2024

BUY
$0.85 - $1.26 $8,760 - $12,986
10,307 Added 72.65%
24,494 $24,000
Q1 2024

May 03, 2024

SELL
$0.91 - $1.75 $134 - $259
-148 Reduced 1.03%
14,187 $18,000
Q4 2023

Feb 05, 2024

BUY
$1.32 - $4.83 $3,872 - $14,171
2,934 Added 25.73%
14,335 $19,000
Q3 2023

Nov 06, 2023

BUY
$3.02 - $4.05 $1,416 - $1,899
469 Added 4.29%
11,401 $34,000
Q2 2023

Jul 27, 2023

SELL
$2.79 - $5.03 $708 - $1,277
-254 Reduced 2.27%
10,932 $35,000
Q1 2023

May 02, 2023

BUY
$3.14 - $8.22 $35,124 - $91,948
11,186 New
11,186 $35,000
Q3 2021

Nov 02, 2021

SELL
$11.24 - $21.0 $13 Million - $24.3 Million
-1,158,015 Closed
0 $0
Q2 2021

Aug 03, 2021

BUY
$18.04 - $22.09 $683,066 - $836,415
37,864 Added 3.38%
1,158,015 $37 Million
Q1 2021

May 04, 2021

SELL
$16.59 - $33.89 $5.61 Million - $11.5 Million
-338,000 Reduced 23.18%
1,120,151 $33.8 Million
Q4 2020

Feb 01, 2021

SELL
$27.5 - $37.92 $1.17 Million - $1.61 Million
-42,385 Reduced 2.82%
1,458,151 $63.1 Million
Q3 2020

Nov 09, 2020

SELL
$34.44 - $43.75 $1.06 Million - $1.34 Million
-30,715 Reduced 2.01%
1,500,536 $81 Million
Q2 2020

Aug 07, 2020

SELL
$27.12 - $45.97 $5.21 Million - $8.84 Million
-192,247 Reduced 11.15%
1,531,251 $93.5 Million
Q1 2020

May 04, 2020

SELL
$26.16 - $63.5 $3.35 Million - $8.12 Million
-127,912 Reduced 6.91%
1,723,498 $79.2 Million
Q4 2019

Feb 06, 2020

BUY
$46.96 - $61.67 $1.14 Million - $1.5 Million
24,262 Added 1.33%
1,851,410 $162 Million
Q4 2019

Feb 04, 2020

BUY
$46.96 - $61.67 $5.69 Million - $7.48 Million
121,257 Added 7.11%
1,827,148 $146 Million
Q3 2019

Nov 12, 2019

BUY
$59.47 - $93.1 $56.7 Million - $88.8 Million
953,591 Added 126.76%
1,705,891 $157 Million
Q2 2019

Aug 15, 2019

BUY
$75.84 - $105.21 $13 Million - $18 Million
171,555 Added 29.54%
752,300 $95.7 Million
Q1 2019

May 03, 2019

BUY
$64.44 - $104.11 $2.55 Million - $4.12 Million
39,580 Added 7.31%
580,745 $91.4 Million
Q4 2018

Feb 05, 2019

BUY
$59.1 - $93.26 $1.84 Million - $2.91 Million
31,157 Added 6.11%
541,165 $53.7 Million
Q3 2018

Nov 01, 2018

SELL
$88.86 - $117.49 $1.35 Million - $1.78 Million
-15,184 Reduced 2.89%
510,008 $74.5 Million
Q2 2018

Aug 02, 2018

SELL
$99.64 - $127.59 $2.86 Million - $3.66 Million
-28,660 Reduced 5.17%
525,192 $82.4 Million
Q1 2018

May 04, 2018

SELL
$105.8 - $150.94 $11.2 Million - $16 Million
-106,159 Reduced 16.08%
553,852 $94.6 Million
Q4 2017

Feb 01, 2018

SELL
$81.25 - $130.7 $8.03 Million - $12.9 Million
-98,780 Reduced 13.02%
660,011 $118 Million
Q3 2017

Oct 27, 2017

SELL
$57.74 - $91.42 $13 Million - $20.5 Million
-224,480 Reduced 22.83%
758,791 $104 Million
Q2 2017

Aug 07, 2017

BUY
N/A
983,271
983,271 $103 Million

Others Institutions Holding BLUE

About bluebird bio, Inc.


  • Ticker BLUE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,121,800
  • Market Cap $708M
  • Description
  • bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...
More about BLUE
Track This Portfolio

Track Victory Capital Management Inc Portfolio

Follow Victory Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.